Loading company…
Riskpilot
← Back to search
Sign in
Get full access
GRY WARSLA AS
AS
Active
Org 926350161
Trondheimsveien 135, 0570 Oslo
Medical specialists activities · NACE 8622
Est. 2021
4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 6,1M
-1% vs 2023
EBITDA margin
12.8%
-33% vs 2023
Equity ratio
52.2%
Financial strength
Net profit 2024
NOK 475K
-39% vs 2023
EBITDA — year on year
NOK millions
4M
3M
2M
1M
0M
3M
2021
1M
-67%
2022
1M
0%
2023
1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 6,1M
-1%
EBITDA
NOK 786K
-33%
Net profit
NOK 475K
-39%
Total assets
NOK 3,1M
+9%
Equity
NOK 1,6M
-12%
Employees
4
—
Company information
Legal name
GRY WARSLA AS
Org number
926350161
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
7. januar 2021
Share capital
NOK 30 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Spesialisert helsetjeneste innen kvinnesykdommer.
Contact
Address
Trondheimsveien 135, 0570 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
2M
3M
5M
7M
5M
2021
5M
2022
6M
2023
6M
2024
EBITDA
NOK millions
0M
1M
2M
3M
3M
3M
2021
1M
2022
1M
2023
1M
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
5 293
5 118
6 214
6 138
Staff expenses
−1 810
−2 445
−3 063
−3 391
EBITDA
2 619
1 239
1 166
786
Depreciation & amort.
−144
−149
−175
−177
EBIT
2 475
1 090
991
609
Net financials
0
−1
3
0
Profit before tax
2 475
1 089
994
609
Tax
542
240
218
134
Net profit
1 933
849
776
475
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
1 621
2 463
2 860
3 121
Equity
752
1 601
1 853
1 628
Long-term debt
32
62
76
99
Short-term debt
837
800
931
1 394
Total debt
869
862
1 007
1 493
Financial ratios
5-year trend
EBITDA margin
12.8%
This company
15.8%
Market median
-19% vs market
2021
2024
Equity ratio
52.2%
This company
38.2%
Market median
+37% vs market
2021
2024
Return on equity
29.2%
This company
18.4%
Market median
+59% vs market
2021
2024
Net profit margin
7.7%
This company
8.1%
Market median
-5% vs market
2021
2024
Asset turnover
1.97×
This company
1.12×
Market median
+76% vs market
2021
2024
Debt / equity
0.92×
This company
0.62×
Market median
+48% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
GW
Gry Warsla
Chief Executive Officer
Chief Executive Officer
2021
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
GRY WARSLA AS
(this company)
CARLBERNERKLINIKKEN AS
Board network connections
Board members of GRY WARSLA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Gry Warsla
Chief Executive Officer
0 companies